Oncology Market - Forecast(2025 - 2031)

Report Code: HCR 1226 Report Format: PDF + Excel

Oncology Market Overview

 Oncology Market Size is estimated to reach 420790 Million by 2030, growing at a CAGR of 11.50% during the forecast period 2024-2030. 
Oncology is a branch of medicine that deals with the prevention, diagnosis, and treatment of cancer. Cancer is a disease, which involves the abnormal growth of cells that result in the formation of a tumor. However, benign tumor are not cancers. The abnormal tumor cells tend to spread to other local tissues and different parts of the body through the blood and lymphatic system. Treatment of cancer depends upon the stages of the disease progression. Increased prevalence of cancer, unhealthy lifestyle, and increasing geriatric population are the primary factors driving the growth of the Oncology Market. High market growth potential in developing nations, rise in the number of pipeline products, and the upsurge in demand for personalized medicines are poised to create new opportunities for the market players during the forecast period 2020-2025. 
 

Oncology Market Report Coverage

The report: “Oncology Market Forecast (2020-2025)”, by Industry ARC, covers an in-depth analysis of the following segments of the Oncology Market. 
 
By Cancer Type: Breast Cancer, Lung Cancer, Kidney cancer, Liver cancer, Ovarian Cancer, Prostate Cancer, Skin Cancer, Pancreatic Cancer, Colorectal, Blood  Cancer, Others
By Therapy Type: Medical Oncology, Radiation Oncology, Surgical Oncology, Others
By  Geography: North America, South America, Asia-Pacific, Europe, Rest of the World
 

Key Takeaways

  • In 2019, North America dominated the Oncology Market owing to emerging biopharma companies in U.S and Canada.
  • Emerging bio pharmacy companies in the U.S. for oncology and the growing concern of people towards health are contributing to the growth of the Oncology Market.
  • Pharma companies that are active in oncology are now in a race to harness new data sources and digital platforms, so they can engage patients, providers, and regulators more effectively, and creating an increase in demand.
  • Detailed analysis on the Strength, Weakness and opportunities of the prominent players operating in the market will be provided in the Oncology Market Report
 

Oncology Market Segment Analysis - By Cancer Type

Based on cancer type the Oncology Market is segmented into Breast Cancer, Lung Cancer, Kidney cancer, Liver cancer, Ovarian Cancer, Prostate Cancer, Skin Cancer, Pancreatic Cancer, Colorectal, Blood Cancer, others. Lung Cancer is the fastest growing segment by cancer type this is owing to consumption of cigarettes and alcohol. Moreover, according to the American Cancer Society about 228,820 new cases of lung cancer is poised to witness in U.S in 2020. 
 

Oncology Market Segment Analysis - By Therapy Type

Based on Therapy type Oncology Market is segmented into Medical Oncology, Radiation Oncology, Surgical Oncology, and others. Medical Oncology is the fastest-growing segment by therapy type and is estimated to grow with CAGR of 12.2% during the forecast period 2020-2025. Medical Oncology is a modality of treatment of cancer care, which uses Chemotherapy, Immunotherapy, Hormonal Therapy, and Targeted Therapy to treat cancer in an effective manner. The food and Drug Administrative (FDA) has approved targeted therapies for the treatment of some patients with the following types of cancers such as bladder cancer, brain cancer, breast cancer, cervical cancer, colorectal cancer, endometrial cancer.
 

Oncology Market Segment Analysis - By Geography

Based on Geography Oncology Market is segmented to North America, South America, Europe, Asia Pacific, and Rest of the world. North America dominated the Oncology Market with market share of 53.19% in 2019. This is owing to emerging bio pharmacy companies in the U.S. for oncology and the growing concern of people towards health are contributing to the growth of the Oncology Market. Asia pacific is estimated to be fastest growing CAGR during the forecast period 2020-2025 owing to high no of cases in India, Taiwan, Malaysia, and China. India has the largest number of Breast Cancer Patients with mortality rates of 55% followed by Oral Cavity Cancer with a mortality rate of 60%. Higher incidence of gallbladder cancer in north India and NE region compared to other parts.
 
Oncology Market
 

Oncology Market Drivers

Higher Prevalence And Incidence Of Cancer Diseases Globally

Need for cancer therapies are rising with the increasing prevalence of cancer cases and deaths. Thus, the Oncology Market is majorly driven by this factor. Besides, focus on drug development for the reduction of cancer cases has also increased. Increasing healthcare expenditure of various countries is also contributing to the market growth. According to WHO in 2018, 9.6 million people worldwide died of cancer. This makes cancer to be one of the leading causes of death globally. The rising incidences of cancer have impelled the cancer therapy industry and have aided the Oncology Market. 
 
Burgeoning Technological Usage Coupled With Increase In Healthcare Spending:
Targeted Therapy has been gaining traction over the years, for cancer treatments. They offer various benefits over other treatment methods such as chemotherapy, radiation, and others. It can be used alone or in combination with other treatments such as radiotherapy or chemotherapy. They are effective, as they do not affect the surrounding cells. These new technologies and methodologies for cancer treatment in developing countries coupled with high healthcare investment are set to aid propel the Oncology Market. 
 

Oncology Market Challenges

Presence of alternatives

In 2017–2018, biosimilar such as rituximab, etanercept, and infliximab saved £210 million from the UK National Health System. The use of biosimilar in oncology practice is currently continually growing as various patents on biologic drugs are expiring. According to U.S. Food and Drug Administration (FDA), biosimilar is a biological product that is highly similar to and has no clinically significant variations in health, purity, and potency from an existing FDA-approved reference product. The growing usage of the biosimilar in oncology is a concern for the growth of other oncology drugs.
 

Multifunctional Food Ingredients industry outlook:

Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in the Oncology Market. Key companies of this market are Aegerion Pharmaceuticals Inc., Abbvie Inc., Ability Pharma, Acadia Pharmaceuticals Inc., Amgen Inc., Takeda Oncology., Aslan Pharmaceuticals Ltd., Aspen Pharmacare Holdings Limited., Astrazeneca, Athenex, Inc. among others.
 

Acquisitions/Product Launches:

  • In May 2019, Amgen Inc., and Syapse Entered Precision Medicine Collaboration In Oncology. Under the terms of the agreement, Amgen and Syapse is set to develop observational research analytics to assess treatment outcomes for areas of unmet need in oncology.
  • In March 28, 2019, AstraZeneca and Daiichi Sankyo entered into a collaboration for novel HER2-targeting antibody-drug conjugate. The collaboration is aligned with AstraZeneca’s science-led strategy in Oncology, which is based on four key scientific platforms: tumors drivers & resistance, DNA damage response, Immuno-Oncology, and ADCs.
  • In April 2018, AbbVie Inc. entered a joint research collaboration to establish the K.C. Nicolaou Research Accelerator. The research at the Accelerator is about to focus on synthesizing novel cytotoxic agents for use in the fight against cancer. The collaboration  complement AbbVie's existing expertise in oncology discovery and early development.

For more Lifesciences and Healthcare related reports, please click here

1. Oncology Market - Overview
    1.1. Definitions and Scope
2. Oncology Market - Executive Summary
    2.1. Market Revenue, Market Size and Key Trends by Company
    2.2. Key trends by Cancer Types
    2.3. Key trends by Therapy Types
    2.4. Key trends by Geography
3. Oncology Market Landscape
    3.1. Comparative Analysis 
        3.1.1. Product Benchmarking – Key Companies
        3.1.2. Top 5 Financial Analysis
        3.1.3. Market value split by Key Companies
        3.1.4. Patent Analysis
4. Oncology Market Forces
    4.1. Market Drivers
    4.2. Market Constraints & Challenges
    4.3. Porters five force model
        4.3.1. Bargaining power of suppliers
        4.3.2. Bargaining powers of customers
        4.3.3. Threat of new entrants
        4.3.4. Rivalry among existing players
        4.3.5. Threat of substitutes 
5. Oncology Market - By Strategic Analysis 
    5.1. Value Chain Analysis
    5.2. Opportunities Analysis
    5.3. Market Life Cycle Analysis
6. Oncology Market- By Cancer Types (Market Size — $Million/$Billion)
    6.1. Breast Cancer
    6.2. Lung Cancer
    6.3. Kidney Cancer
    6.4. Liver Cancer
    6.5. Ovarian Cancer
    6.6. Prostate cancer
    6.7. Skin Cancer
    6.8. Pancreatic Cancer
    6.9. Colorectal Cancer
    6.10. Blood Cancer
    6.11. Others
7. Oncology Market - By Therapy Type (Market Size — $Million/$Billion)
    7.1. Medical Oncology
        7.1.1. Chemotherapy
        7.1.2. Targeted Therapy
        7.1.3. Immunotherapy
        7.1.4. Hormonal Therapy
        7.1.5. Others
    7.2. Radiation Oncology
        7.2.1. External Radiation Therapy
        7.2.2. Internal Radiation Therapy
    7.3. Surgical Oncology
        7.3.1. Laparoscopic Surgery
        7.3.2. Robotic Surgery
    7.4. Others
8. Oncology Market - By Geography (Market Size — $Million/$Billion)
    8.1. North America 
        8.1.1. U.S. 
        8.1.2. Canada 
        8.1.3. Mexico  
    8.2. South America
        8.2.1. Brazil
        8.2.2. Venezuela
        8.2.3. Argentina
        8.2.4. Ecuador
        8.2.5. Peru
        8.2.6. Colombia
        8.2.7. Costa Rica
        8.2.8. Others
    8.3. Europe 
        8.3.1. U.K 
        8.3.2. Germany 
        8.3.3. Italy 
        8.3.4. France
        8.3.5. Netherlands
        8.3.6. Belgium
        8.3.7. Spain
        8.3.8. Denmark
        8.3.9. Rest of Europe
    8.4. Asia Pacific
        8.4.1. China 
        8.4.2. Australia
        8.4.3. Japan
        8.4.4. South Korea
        8.4.5. India
        8.4.6. Taiwan
        8.4.7. Malaysia
        8.4.8. Rest of APAC
    8.5. Rest of the World
        8.5.1. Middle East
        8.5.2. Africa
9. Oncology Market- Entropy
10. Oncology Market – Key Company Profiles (Overview, Financials, Developments, Product Portfolio)
    10.1. Company 1
    10.2. Company 2
    10.3. Company 3
    10.4. Company 4
    10.5. Company 5
    10.6. Company 6
    10.7. Company 7
    10.8. Company 8
    10.9. Company 9
    10.10. Company 10 and more
"*Financials would be provided on a best efforts basis for private companies"

List of Tables

Table 1: Oncology Market Overview 2023-2030
Table 2: Oncology Market Leader Analysis 2023-2030 (US$)
Table 3: Oncology Market Product Analysis 2023-2030 (US$)
Table 4: Oncology Market End User Analysis 2023-2030 (US$)
Table 5: Oncology Market Patent Analysis 2013-2023* (US$)
Table 6: Oncology Market Financial Analysis 2023-2030 (US$)
Table 7: Oncology Market Driver Analysis 2023-2030 (US$)
Table 8: Oncology Market Challenges Analysis 2023-2030 (US$)
Table 9: Oncology Market Constraint Analysis 2023-2030 (US$)
Table 10: Oncology Market Supplier Bargaining Power Analysis 2023-2030 (US$)
Table 11: Oncology Market Buyer Bargaining Power Analysis 2023-2030 (US$)
Table 12: Oncology Market Threat of Substitutes Analysis 2023-2030 (US$)
Table 13: Oncology Market Threat of New Entrants Analysis 2023-2030 (US$)
Table 14: Oncology Market Degree of Competition Analysis 2023-2030 (US$)
Table 15: Oncology Market Value Chain Analysis 2023-2030 (US$)
Table 16: Oncology Market Pricing Analysis 2023-2030 (US$)
Table 17: Oncology Market Opportunities Analysis 2023-2030 (US$)
Table 18: Oncology Market Product Life Cycle Analysis 2023-2030 (US$)
Table 19: Oncology Market Supplier Analysis 2023-2030 (US$)
Table 20: Oncology Market Distributor Analysis 2023-2030 (US$)
Table 21: Oncology Market Trend Analysis 2023-2030 (US$)
Table 22: Oncology Market Size 2023 (US$)
Table 23: Oncology Market Forecast Analysis 2023-2030 (US$)
Table 24: Oncology Market Sales Forecast Analysis 2023-2030 (Units)
Table 25: Oncology Market, Revenue & Volume, BY CANCER TYPE, 2023-2030 ($)
Table 26: Oncology Market BY CANCER TYPE, Revenue & Volume, By Breast Cancer, 2023-2030 ($)
Table 27: Oncology Market BY CANCER TYPE, Revenue & Volume, By Lung Cancer, 2023-2030 ($)
Table 28: Oncology Market, Revenue & Volume, BY THERAPY TYPE, 2023-2030 ($)
Table 29: Oncology Market BY THERAPY TYPE, Revenue & Volume, By Medical Oncology, 2023-2030 ($)
Table 30: North America Oncology Market, Revenue & Volume, BY CANCER TYPE, 2023-2030 ($)
Table 31: North America Oncology Market, Revenue & Volume, BY THERAPY TYPE, 2023-2030 ($)
Table 32: South america Oncology Market, Revenue & Volume, BY CANCER TYPE, 2023-2030 ($)
Table 33: South america Oncology Market, Revenue & Volume, BY THERAPY TYPE, 2023-2030 ($)
Table 34: Europe Oncology Market, Revenue & Volume, BY CANCER TYPE, 2023-2030 ($)
Table 35: Europe Oncology Market, Revenue & Volume, BY THERAPY TYPE, 2023-2030 ($)
Table 36: APAC Oncology Market, Revenue & Volume, BY CANCER TYPE, 2023-2030 ($)
Table 37: APAC Oncology Market, Revenue & Volume, BY THERAPY TYPE, 2023-2030 ($)
Table 38: Middle East & Africa Oncology Market, Revenue & Volume, BY CANCER TYPE, 2023-2030 ($)
Table 39: Middle East & Africa Oncology Market, Revenue & Volume, BY THERAPY TYPE, 2023-2030 ($)
Table 40: Russia Oncology Market, Revenue & Volume, BY CANCER TYPE, 2023-2030 ($)
Table 41: Russia Oncology Market, Revenue & Volume, BY THERAPY TYPE, 2023-2030 ($)
Table 42: Israel Oncology Market, Revenue & Volume, BY CANCER TYPE, 2023-2030 ($)
Table 43: Israel Oncology Market, Revenue & Volume, BY THERAPY TYPE, 2023-2030 ($)
Table 44: Top Companies 2023 (US$)Oncology Market, Revenue & Volume
Table 45: Product Launch 2023-2030Oncology Market, Revenue & Volume
Table 46: Mergers & Acquistions 2023-2030Oncology Market, Revenue & Volume


List of Figures

Figure 1: Overview of Oncology Market 2023-2030
Figure 2: Market Share Analysis for Oncology Market 2023 (US$)
Figure 3: Product Comparison in Oncology Market 2023-2030 (US$)
Figure 4: End User Profile for Oncology Market 2023-2030 (US$)
Figure 5: Patent Application and Grant in Oncology Market 2013-2023* (US$)
Figure 6: Top 5 Companies Financial Analysis in Oncology Market 2023-2030 (US$)
Figure 7: Market Entry Strategy in Oncology Market 2023-2030
Figure 8: Ecosystem Analysis in Oncology Market 2023
Figure 9: Average Selling Price in Oncology Market 2023-2030
Figure 10: Top Opportunites in Oncology Market 2023-2030
Figure 11: Market Life Cycle Analysis in Oncology Market
Figure 12: GlobalBY CANCER TYPEOncology Market Revenue, 2023-2030 ($)
Figure 13: GlobalBY THERAPY TYPEOncology Market Revenue, 2023-2030 ($)
Figure 14: Global Oncology Market - By Geography
Figure 15: Global Oncology Market Value & Volume, By Geography, 2023-2030 ($) 
Figure 16: Global Oncology Market CAGR, By Geography, 2023-2030 (%)
Figure 17: North America Oncology Market Value & Volume, 2023-2030 ($)
Figure 18: US Oncology Market Value & Volume, 2023-2030 ($)
Figure 19: US GDP and Population, 2023-2030 ($)
Figure 20: US GDP – Composition of 2023, By Sector of Origin
Figure 21: US Export and Import Value & Volume, 2023-2030 ($)
Figure 22: Canada Oncology Market Value & Volume, 2023-2030 ($)
Figure 23: Canada GDP and Population, 2023-2030 ($)
Figure 24: Canada GDP – Composition of 2023, By Sector of Origin
Figure 25: Canada Export and Import Value & Volume, 2023-2030 ($)
Figure 26: Mexico Oncology Market Value & Volume, 2023-2030 ($)
Figure 27: Mexico GDP and Population, 2023-2030 ($)
Figure 28: Mexico GDP – Composition of 2023, By Sector of Origin
Figure 29: Mexico Export and Import Value & Volume, 2023-2030 ($)
Figure 30: South America Oncology Market Value & Volume, 2023-2030 ($)
Figure 31: Brazil Oncology Market Value & Volume, 2023-2030 ($)
Figure 32: Brazil GDP and Population, 2023-2030 ($)
Figure 33: Brazil GDP – Composition of 2023, By Sector of Origin
Figure 34: Brazil Export and Import Value & Volume, 2023-2030 ($)
Figure 35: Venezuela Oncology Market Value & Volume, 2023-2030 ($)
Figure 36: Venezuela GDP and Population, 2023-2030 ($)
Figure 37: Venezuela GDP – Composition of 2023, By Sector of Origin
Figure 38: Venezuela Export and Import Value & Volume, 2023-2030 ($)
Figure 39: Argentina Oncology Market Value & Volume, 2023-2030 ($)
Figure 40: Argentina GDP and Population, 2023-2030 ($)
Figure 41: Argentina GDP – Composition of 2023, By Sector of Origin
Figure 42: Argentina Export and Import Value & Volume, 2023-2030 ($)
Figure 43: Ecuador Oncology Market Value & Volume, 2023-2030 ($)
Figure 44: Ecuador GDP and Population, 2023-2030 ($)
Figure 45: Ecuador GDP – Composition of 2023, By Sector of Origin
Figure 46: Ecuador Export and Import Value & Volume, 2023-2030 ($)
Figure 47: Peru Oncology Market Value & Volume, 2023-2030 ($)
Figure 48: Peru GDP and Population, 2023-2030 ($)
Figure 49: Peru GDP – Composition of 2023, By Sector of Origin
Figure 50: Peru Export and Import Value & Volume, 2023-2030 ($)
Figure 51: Colombia Oncology Market Value & Volume, 2023-2030 ($)
Figure 52: Colombia GDP and Population, 2023-2030 ($)
Figure 53: Colombia GDP – Composition of 2023, By Sector of Origin
Figure 54: Colombia Export and Import Value & Volume, 2023-2030 ($)
Figure 55: Costa Rica Oncology Market Value & Volume, 2023-2030 ($)
Figure 56: Costa Rica GDP and Population, 2023-2030 ($)
Figure 57: Costa Rica GDP – Composition of 2023, By Sector of Origin
Figure 58: Costa Rica Export and Import Value & Volume, 2023-2030 ($)
Figure 59: Europe Oncology Market Value & Volume, 2023-2030 ($)
Figure 60: U.K Oncology Market Value & Volume, 2023-2030 ($)
Figure 61: U.K GDP and Population, 2023-2030 ($)
Figure 62: U.K GDP – Composition of 2023, By Sector of Origin
Figure 63: U.K Export and Import Value & Volume, 2023-2030 ($)
Figure 64: Germany Oncology Market Value & Volume, 2023-2030 ($)
Figure 65: Germany GDP and Population, 2023-2030 ($)
Figure 66: Germany GDP – Composition of 2023, By Sector of Origin
Figure 67: Germany Export and Import Value & Volume, 2023-2030 ($)
Figure 68: Italy Oncology Market Value & Volume, 2023-2030 ($)
Figure 69: Italy GDP and Population, 2023-2030 ($)
Figure 70: Italy GDP – Composition of 2023, By Sector of Origin
Figure 71: Italy Export and Import Value & Volume, 2023-2030 ($)
Figure 72: France Oncology Market Value & Volume, 2023-2030 ($)
Figure 73: France GDP and Population, 2023-2030 ($)
Figure 74: France GDP – Composition of 2023, By Sector of Origin
Figure 75: France Export and Import Value & Volume, 2023-2030 ($)
Figure 76: Netherlands Oncology Market Value & Volume, 2023-2030 ($)
Figure 77: Netherlands GDP and Population, 2023-2030 ($)
Figure 78: Netherlands GDP – Composition of 2023, By Sector of Origin
Figure 79: Netherlands Export and Import Value & Volume, 2023-2030 ($)
Figure 80: Belgium Oncology Market Value & Volume, 2023-2030 ($)
Figure 81: Belgium GDP and Population, 2023-2030 ($)
Figure 82: Belgium GDP – Composition of 2023, By Sector of Origin
Figure 83: Belgium Export and Import Value & Volume, 2023-2030 ($)
Figure 84: Spain Oncology Market Value & Volume, 2023-2030 ($)
Figure 85: Spain GDP and Population, 2023-2030 ($)
Figure 86: Spain GDP – Composition of 2023, By Sector of Origin
Figure 87: Spain Export and Import Value & Volume, 2023-2030 ($)
Figure 88: Denmark Oncology Market Value & Volume, 2023-2030 ($)
Figure 89: Denmark GDP and Population, 2023-2030 ($)
Figure 90: Denmark GDP – Composition of 2023, By Sector of Origin
Figure 91: Denmark Export and Import Value & Volume, 2023-2030 ($)
Figure 92: APAC Oncology Market Value & Volume, 2023-2030 ($)
Figure 93: China Oncology Market Value & Volume, 2023-2030
Figure 94: China GDP and Population, 2023-2030 ($)
Figure 95: China GDP – Composition of 2023, By Sector of Origin
Figure 96: China Export and Import Value & Volume, 2023-2030 ($)Oncology Market China Export and Import Value & Volume, 2023-2030 ($)
Figure 97: Australia Oncology Market Value & Volume, 2023-2030 ($)
Figure 98: Australia GDP and Population, 2023-2030 ($)
Figure 99: Australia GDP – Composition of 2023, By Sector of Origin
Figure 100: Australia Export and Import Value & Volume, 2023-2030 ($)
Figure 101: South Korea Oncology Market Value & Volume, 2023-2030 ($)
Figure 102: South Korea GDP and Population, 2023-2030 ($)
Figure 103: South Korea GDP – Composition of 2023, By Sector of Origin
Figure 104: South Korea Export and Import Value & Volume, 2023-2030 ($)
Figure 105: India Oncology Market Value & Volume, 2023-2030 ($)
Figure 106: India GDP and Population, 2023-2030 ($)
Figure 107: India GDP – Composition of 2023, By Sector of Origin
Figure 108: India Export and Import Value & Volume, 2023-2030 ($)
Figure 109: Taiwan Oncology Market Value & Volume, 2023-2030 ($)
Figure 110: Taiwan GDP and Population, 2023-2030 ($)
Figure 111: Taiwan GDP – Composition of 2023, By Sector of Origin
Figure 112: Taiwan Export and Import Value & Volume, 2023-2030 ($)
Figure 113: Malaysia Oncology Market Value & Volume, 2023-2030 ($)
Figure 114: Malaysia GDP and Population, 2023-2030 ($)
Figure 115: Malaysia GDP – Composition of 2023, By Sector of Origin
Figure 116: Malaysia Export and Import Value & Volume, 2023-2030 ($)
Figure 117: Hong Kong Oncology Market Value & Volume, 2023-2030 ($)
Figure 118: Hong Kong GDP and Population, 2023-2030 ($)
Figure 119: Hong Kong GDP – Composition of 2023, By Sector of Origin
Figure 120: Hong Kong Export and Import Value & Volume, 2023-2030 ($)
Figure 121: Middle East & Africa Oncology Market Middle East & Africa 3D Printing Market Value & Volume, 2023-2030 ($)
Figure 122: Russia Oncology Market Value & Volume, 2023-2030 ($)
Figure 123: Russia GDP and Population, 2023-2030 ($)
Figure 124: Russia GDP – Composition of 2023, By Sector of Origin
Figure 125: Russia Export and Import Value & Volume, 2023-2030 ($)
Figure 126: Israel Oncology Market Value & Volume, 2023-2030 ($)
Figure 127: Israel GDP and Population, 2023-2030 ($)
Figure 128: Israel GDP – Composition of 2023, By Sector of Origin
Figure 129: Israel Export and Import Value & Volume, 2023-2030 ($)
Figure 130: Entropy Share, By Strategies, 2023-2030* (%)Oncology Market
Figure 131: Developments, 2023-2030*Oncology Market
Figure 132: Company 1 Oncology Market Net Revenue, By Years, 2023-2030* ($)
Figure 133: Company 1 Oncology Market Net Revenue Share, By Business segments, 2023 (%)
Figure 134: Company 1 Oncology Market Net Sales Share, By Geography, 2023 (%)
Figure 135: Company 2 Oncology Market Net Revenue, By Years, 2023-2030* ($)
Figure 136: Company 2 Oncology Market Net Revenue Share, By Business segments, 2023 (%)
Figure 137: Company 2 Oncology Market Net Sales Share, By Geography, 2023 (%)
Figure 138: Company 3 Oncology Market Net Revenue, By Years, 2023-2030* ($)
Figure 139: Company 3 Oncology Market Net Revenue Share, By Business segments, 2023 (%)
Figure 140: Company 3 Oncology Market Net Sales Share, By Geography, 2023 (%)
Figure 141: Company 4 Oncology Market Net Revenue, By Years, 2023-2030* ($)
Figure 142: Company 4 Oncology Market Net Revenue Share, By Business segments, 2023 (%)
Figure 143: Company 4 Oncology Market Net Sales Share, By Geography, 2023 (%)
Figure 144: Company 5 Oncology Market Net Revenue, By Years, 2023-2030* ($)
Figure 145: Company 5 Oncology Market Net Revenue Share, By Business segments, 2023 (%)
Figure 146: Company 5 Oncology Market Net Sales Share, By Geography, 2023 (%)
Figure 147: Company 6 Oncology Market Net Revenue, By Years, 2023-2030* ($)
Figure 148: Company 6 Oncology Market Net Revenue Share, By Business segments, 2023 (%)
Figure 149: Company 6 Oncology Market Net Sales Share, By Geography, 2023 (%)
Figure 150: Company 7 Oncology Market Net Revenue, By Years, 2023-2030* ($)
Figure 151: Company 7 Oncology Market Net Revenue Share, By Business segments, 2023 (%)
Figure 152: Company 7 Oncology Market Net Sales Share, By Geography, 2023 (%)
Figure 153: Company 8 Oncology Market Net Revenue, By Years, 2023-2030* ($)
Figure 154: Company 8 Oncology Market Net Revenue Share, By Business segments, 2023 (%)
Figure 155: Company 8 Oncology Market Net Sales Share, By Geography, 2023 (%)
Figure 156: Company 9 Oncology Market Net Revenue, By Years, 2023-2030* ($)
Figure 157: Company 9 Oncology Market Net Revenue Share, By Business segments, 2023 (%)
Figure 158: Company 9 Oncology Market Net Sales Share, By Geography, 2023 (%)
Figure 159: Company 10 Oncology Market Net Revenue, By Years, 2023-2030* ($)
Figure 160: Company 10 Oncology Market Net Revenue Share, By Business segments, 2023 (%)
Figure 161: Company 10 Oncology Market Net Sales Share, By Geography, 2023 (%)
Figure 162: Company 11 Oncology Market Net Revenue, By Years, 2023-2030* ($)
Figure 163: Company 11 Oncology Market Net Revenue Share, By Business segments, 2023 (%)
Figure 164: Company 11 Oncology Market Net Sales Share, By Geography, 2023 (%)
Figure 165: Company 12 Oncology Market Net Revenue, By Years, 2023-2030* ($)
Figure 166: Company 12 Oncology Market Net Revenue Share, By Business segments, 2023 (%)
Figure 167: Company 12 Oncology Market Net Sales Share, By Geography, 2023 (%)
Figure 168: Company 13 Oncology Market Net Revenue, By Years, 2023-2030* ($)
Figure 169: Company 13 Oncology Market Net Revenue Share, By Business segments, 2023 (%)
Figure 170: Company 13 Oncology Market Net Sales Share, By Geography, 2023 (%)
Figure 171: Company 14 Oncology Market Net Revenue, By Years, 2023-2030* ($)
Figure 172: Company 14 Oncology Market Net Revenue Share, By Business segments, 2023 (%)
Figure 173: Company 14 Oncology Market Net Sales Share, By Geography, 2023 (%)
Figure 174: Company 15 Oncology Market Net Revenue, By Years, 2023-2030* ($)
Figure 175: Company 15 Oncology Market Net Revenue Share, By Business segments, 2023 (%)
Figure 176: Company 15 Oncology Market Net Sales Share, By Geography, 2023 (%)